Cell
Volume 67, Issue 4, 15 November 1991, Pages 723-730
Journal home page for Cell

Identification of a Gs activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation

https://doi.org/10.1016/0092-8674(91)90067-9Get rights and content

Abstract

We have localized a G protein activator region of the human β2-adrenergic receptor to region βIII-2 (from Arg259 to Lys273). The synthetic βIII-2, corresponding to the C-terminal end of the third cytoplasmic loop, activates Gs at nanomolar concentrations and weakly activates Gi. βIII-2 activates adenylyl cyclase at nanomolar concentrations in wild-type S49 lymphoma membranes, but not in membranes of unc mutant S49 cells, in which Gs is uncoupled from β-adrenergic stimulation. Phosphorylation of βIII-2 by cAMP-dependent protein kinase A, which is involved in the desensitization of the β-adrenergic receptor from Gs, drastically reduces the effect of βIII-2 on Gs while potentiating its action on Gi, resulting in a total loss of adenylyl cyclase-stimulating activity. These findings indicate that this receptor sequence is a multipotential G protein activator whose G protein specificity is regulated by protein kinase A.

References (38)

Cited by (256)

  • Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential

    2019, Pharmacology and Therapeutics
    Citation Excerpt :

    This peptide activates Gs at nanomolar concentrations in vitro and weakly activates Gi. Whereas, PKA-mediated phosphorylation at the conserved RRXS site dramatically reduced Gs activation, but enhanced Gi activation (Okamoto et al., 1991). Phosphorylation-dependent switch of coupling to non-cognate G protein pathways has also been reported for many GPCRs including adrenergic β1 and β2 (Martin, Whalen, Zamah, Pierce, & Lefkowitz, 2004; Zamah, Delahunty, Luttrell, & Lefkowitz, 2002), prostanoid IP receptor (Miggin & Kinsella, 2002), μOR and δOR (Kramer, Andria, Esposito, & Simon, 2000; Zhang, Zhao, Qiu, Loh, & Law, 2009), CB1R (Paquette et al., 2007), and glutamate mGluR5 (Dupont, Loomekandja Lokenye, & Challiss, 2011).

  • Novel insights in β-adrenergic receptor signaling

    2018, Encyclopedia of Endocrine Diseases
View all citing articles on Scopus
View full text